Primary lung cancer in children and adolescents
- PMID: 38695944
- PMCID: PMC11065912
- DOI: 10.1007/s00432-024-05750-1
Primary lung cancer in children and adolescents
Abstract
Purpose: Primary lung cancer is extremely rare in children and adolescents. The aim of this study is to clarify clinical features and outcomes of primary lung cancer in children and adolescents.
Methods: Young patients (aged ≤ 20 years) diagnosed as primary lung cancer between 2012 and 2023 were retrospective reviewed. According to radiological appearance of the nodules, they were divided into solid nodule (SN) group and ground glass opacity (GGO) group.
Results: A total of 74 patients were identified, with a median age at diagnosis of 18 years old (range: 11-20), including 7 patients in SN group and 67 patients in GGO group. In the GGO group, none of the nodules enlarged or changed during an average surveillance period of 10.8 months before surgery, except one. Wedge resection was the most common procedure (82.1%), followed by segmentectomy (16.4%) and lobectomy (1.5%). Histopathological analysis revealed that 64.2% of GGO nodules were adenocarcinoma in situ and minimally invasive adenocarcinomas, while the remaining 35.8% were invasive adenocarcinomas. Mutational analysis was performed in nine patients, with mutations identified in all cases. After a mean follow-up period of 1.73 ± 1.62 years, two patients in the SN group died due to multiple distant metastases, while all patients in the GGO group survived without recurrence. The overall survival (100%) of the GGO group was significantly higher than SN group (66.7%).
Conclusions: Primary lung cancer in children and adolescents are rare and histopathological heterogeneous. Persistent GGO nodules may indicate early-stage lung adenocarcinoma in children and adolescents.
Keywords: Adolescents; Children; Ground glass opacity; Primary lung cancer; Solid nodule.
© 2024. The Author(s).
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11065912/bin/432_2024_5750_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11065912/bin/432_2024_5750_Fig2_HTML.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11065912/bin/432_2024_5750_Fig3_HTML.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11065912/bin/432_2024_5750_Fig4_HTML.gif)
Similar articles
-
Ground glass opacity resection extent assessment trial (GREAT): A study protocol of multi-institutional, prospective, open-label, randomized phase III trial of minimally invasive segmentectomy versus lobectomy for ground glass opacity (GGO)-containing early-stage invasive lung adenocarcinoma.Front Oncol. 2023 Jan 19;13:1052796. doi: 10.3389/fonc.2023.1052796. eCollection 2023. Front Oncol. 2023. PMID: 36741022 Free PMC article.
-
Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.Chest. 2014 Jan;145(1):66-71. doi: 10.1378/chest.13-1094. Chest. 2014. PMID: 24551879
-
Clinical features and surgical outcomes of young patients with lung adenocarcinoma manifesting as ground glass opacity.Front Oncol. 2022 Sep 14;12:979522. doi: 10.3389/fonc.2022.979522. eCollection 2022. Front Oncol. 2022. PMID: 36185186 Free PMC article.
-
Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.J Thorac Imaging. 2011 May;26(2):106-18. doi: 10.1097/RTI.0b013e3181fbaa64. J Thorac Imaging. 2011. PMID: 21508733 Review.
-
Management of Ground-Glass Opacities in the Lung Cancer Spectrum.Ann Thorac Surg. 2020 Dec;110(6):1796-1804. doi: 10.1016/j.athoracsur.2020.04.094. Epub 2020 Jun 7. Ann Thorac Surg. 2020. PMID: 32525031 Review.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical